We recently published 10 Stocks Jim Cramer Discussed As He Dismissed A Recession. RH (NYSE:RH) is one of the stocks Jim Cramer recently discussed. RH (NYSE:RH) is back on Jim Cramer’s radar as hopes of an interest rate cut lift home building and housing stocks. Its shares have lost a whopping 39% year-to-date but jumped by 13.5% last week as investors bet on mortgage rates dropping following an anticipated interest rate cut. Cramer’s previous comments about RH (NYSE:RH) have wondered whether its industry ...

We recently published 10 Stocks Jim Cramer Discussed As He Dismissed A Recession. e.l.f. Beauty, Inc. (NYSE:ELF) is one of the stocks Jim Cramer recently discussed. e.l.f. Beauty, Inc. (NYSE:ELF)’s shares have gained 9.2% year-to-date after going through a rollercoaster during the year’s first half. Since their post-Liberation Day bottom, the stock has gained 149%. The stock suffered due to the firm’s exposure to tariffs since it sources from China. However, e.l.f. Beauty, Inc. (NYSE:ELF)’s shares have pe ...

At the time of my last update on the Canadian gold miner Agnico Eagle Mines Limited (NYSE: AEM ) in June, the stock was already up by a strong 59% YTD. Since then, it has strengthened even further, with anotherManika is a macroeconomist with over 20 years of experience in industries including investment management, stock broking, investment banking. She also runs the profile Long Term Tips [LTT], which focuses on the generational opportunity in the green economy. Her investing group, Green Growth Giants , t ...

EnglishItalianoEspañolPortuguêsDeutschالعربيةFrançaisImportant DisclaimersThe content provided on the website includes general news and publications, our personal analysis and opinions, and contents provided by third parties, which are intended for educational and research purposes only. It does not constitute, and should not be read as, any recommendation or advice to take any action whatsoever, including to make any investment or buy any product. When making any financial decision, you should perform your ...

US stocks crept higher on Tuesday as investors waited for a revision to jobs numbers, seen as likely to show further labor-market weakness that could reset expectations for interest-rate cuts. The Dow Jones Industrial Average (^DJI) nudged up less than 0.1%, while the S&P 500 (^GSPC) and the tech-heavy Nasdaq Composite (^IXIC) gained around 0.1% after stocks rose on Monday to stay in record-high territory. Markets are treading cautiously on Tuesday as a revised look at US employment looms, with the regu ...

We recently published 10 Stocks Jim Cramer Discussed As He Dismissed A Recession. International Business Machines Corporation (NYSE:IBM) is one of the stocks Jim Cramer recently discussed. International Business Machines Corporation (NYSE:IBM) has shaped up to be a top Cramer enterprise computing stock. Its shares have gained 15% year-to-date despite having lost 9.9% since the firm’s latest earnings report, which saw it disappoint investors with its software revenue. With the NFL season in full swing, Cra ...

Brown Advisory, an investment management company, released its “Brown Advisory Large-Cap Growth Strategy” second-quarter 2025 investor letter. A copy of the letter can be downloaded here. The Brown Advisory Large-Cap Growth strategy has shown resilience this year amid heightened volatility, protecting investor capital during market declines and participating in the strong rebound since early April. The strategy returned 16% during the second quarter, slightly underperforming the benchmark, the Russell 1000® ...

We recently published 10 Stocks Jim Cramer Discussed As He Dismissed A Recession. Salesforce, Inc. (NYSE:CRM) is one of the stocks Jim Cramer recently discussed. Salesforce, Inc. (NYSE:CRM)’s shares have lost more than 23% year-to-date as the firm struggles in the software stock winter in today’s AI-driven market. Investors are worried that since AI enables businesses to easily program software, their reliance on SaaS firms like Salesforce, Inc. (NYSE:CRM) is lessening. The shares fell by 4.9% after the f ...

Core Viewpoint - Novartis has agreed to acquire Tourmaline Bio for $1.4 billion, following promising results for Tourmaline's cardiovascular drug, pacibekitug, which showed significant efficacy in reducing hs-CRP levels in patients [1][2]. Group 1: Acquisition Details - The acquisition deal is valued at $1.4 billion, indicating Novartis's strategic interest in expanding its portfolio in the cardiovascular space [1]. - Tourmaline Bio's shares surged by 58% to $47.68 in premarket trading following the announcement of the acquisition [4]. Group 2: Drug Efficacy and Market Position - Tourmaline's drug, pacibekitug, demonstrated that up to 65% of patients experienced deep reductions in hs-CRP, a key indicator of cardiovascular disease [2]. - In a previous study, quarterly doses of pacibekitug resulted in a median reduction of hs-CRP by 85% after 90 days of treatment, positioning it competitively against Novo Nordisk's ziltivekimab [3]. Group 3: Analyst Insights - Wedbush analyst Laura Chico noted that the timing of the acquisition aligns well with Tourmaline's updated data and plans for Phase 3 testing, suggesting a logical partnership with Novartis due to its expertise in cardiometabolic health [3].

We recently published 10 Stocks Jim Cramer Discussed As He Dismissed A Recession. Broadcom Inc. (NASDAQ:AVGO) is one of the stocks Jim Cramer recently discussed. Joao Virissimo/Shutterstock.com Broadcom Inc. (NASDAQ:AVGO) stunned the stock market and the AI sector when it revealed that it had landed a $10 billion deal for custom AI chips. The announcement, paired with a strong earnings report, sent the stock 13.7% higher. Cramer discussed the potential of OpenAI moving away from NVIDIA to Broadcom: “[O ...